Facebook Twitter YouTube RSS
  • Search this Website
Sama - Resource Group for Women and Health
 
Skip to content
  • About Us
    • Our Vision & Mission
    • Intervention Strategies
    • Member – Government Committees
    • Annual Reports
    • Our Trustees
    • Donors
    • FCRA Information
  • Our Work
    • Pandemics & Covid-19
      • Helplines
      • Statements
      • High Court Order
      • Articles
      • Community Voices
      • Relief & Other Support for Covid-19
      • Intersectional Feminist Framework
      • Consultations on Gender, Equity & Covid-19 Vaccines
      • Webinar Series Pandemics & Public Health
      • Webinar Series on Vaccine Research & Access
      • Webinars on Covid-19
      • Videos and Podcasts
    • Public Health & Right to Health
    • Surrogacy & ARTs
      • Conference Participation & Seminars
      • Workshops & Discussions
      • Reports & Studies
      • Consultations
      • Film / Media
      • Policy Level Advocacy
      • Publications
      • Media Resources
    • Gender Based Violence
    • Reproductive and Disability Justice & Sickle Cell Disease
    • Sexual and Reproductive Health
    • Ethics in Clinical Trials, Access to Medicines
    • Young Women and Mental Health
    • Bioethics
    • Early Marriage and Health
    • Population Policies & Two Child Norm
  • Publications
    • Research Reports
    • Consultation Reports
    • Policy Briefs
    • Capacity Building Tools
    • Fact Finding Reports
    • Articles and Edited Volumes
    • Blogposts
    • Posters
    • Films & Videos
  • Archives
    • Clinical Trials
      • General
      • Affordability
      • Availability & Accessability
      • Compensation
      • Informed Consent
      • Recuritment
      • Bioethics
      • Guidelines & Legislations
  • Photo Gallery
  • Contact
  • Support Us

Category: Archives

As red tape grows, pharma research flees India

  By admin Archives, Clinical Trials, General

Editorial Comment | Business Standard | New Delhi | 8 September 2014 Piramal Enterprises, the Piramal group’s flagship company operating primarily in the healthcare sector, has decided to close its Mumbai drug research and development (R&D) unit, its largest in… Continue reading

Current perspective of severe adverse events and compensation requirements in India

  By admin Archives, Clinical Trials, Compensation

Shekhar Goyal, Akhil Kapoor, Indra Bhadu | International Journal of Clinical Trials | 2014 Aug;1(2):76-77 Abstract As per Drug Controller General of India (DCGI), there are clear cut compensation guidelines for clinical trial participants in case of death and injury after… Continue reading

Centre, ICMR to Produce Files Relating to Cancer Drugs Licence

  By admin Archives, Clinical Trials, General

The New Indian Express | PTI | 12 August 2014 NEW DELHI: The Supreme Court today directed the Centre’s competent authority to place before it the file relating to licences given for the administration of two vaccines for cervical cancer prevention.… Continue reading

5 Ways Smartphones Can Improve Clinical Trials

  By admin Archives, Clinical Trials, General

Erez Raphael | Med Gadget | 6 August 2014 When it comes to bringing better drugs to market, clinical research is a critical step. Enormous time is spent proving that a product is safe and effective. Yet several common inefficiencies tend… Continue reading

Clinical Trials may be Compromised by Online Patient Chatter

  By admin Archives, Clinical Trials, General

Ed Silverman | The Wall Street Journal | 30 July 2014 Are patients jeopardizing clinical trials by discussing them on social media? There is growing fear in the medical community and the pharmaceutical industry that an increasing number of people… Continue reading

Biotech cos, herbal majors object to levy of 12.3% service tax on clinical trials in Union budget

  By admin Archives, Clinical Trials, General

Nandita Vijay | Pharmabiz.com | Bengaluru | 21 July 2014 Bio-pharma companies, herbal drug majors and the Indian Society for Clinical Research (ISCR) have taken objection to the proposal to levy a service tax of 12.3 per cent as it… Continue reading

«‹23456›»
  • What’s New

    • Health without violence: Comprehensive response to GBV
    • Multiple Patriarchies, Collective Struggles: Gender Justice, Laws and Perspectives
    • Multiple Patriarchies, Collectivised Struggles: An online session
    • Shifting Perspectives: Recognising GBV as a Public Health Issue
    • Short course on GBV in Bhopal
    • We will miss you, Philo …
    • “Can we hear the cuckoo’s voice?”: The unforgettable Vivaldi and the climate crisis
    • Webinar: Racial and Structural Disparities in Health: Rights, Treatment, and Care for People with SCD
    • 16 Days of Activism Against GBV 2024
    • Short Course on Addressing GBV as a Public Health Concern
    • Challenging Control: The Continuing Struggle for Sexual and Reproductive Health Rights
  • Building Capacities and Leadership

    Our training and capacity-building initiatives are designed to strengthen women’s and young people’s (especially young women and girls) leadership in rural and peri-urban … Read more »

  • Research

    Over the last 25 years, Sama – Resource Group for Women and Health has conducted research on wide-ranging issues related to women’s health, public health, mental health, gender-based violence (GBV), and sexual and reproductive … Read more »

  • Advocacy

    With our strong and expanding connections at both the policy and grassroots levels, we are well placed to shape policy initiatives that reflect ground realities. We also create platforms that support community … Read more »

  • Knowledge Creation

    The knowledge resources we create cover a broad range of formats, including research papers, essays, articles, podcasts, training modules, policy briefs, information guides, videos, booklets, and posters … Read more »

  • About Us
  • Our Work
  • Publications
  • Archives
  • Photo Gallery
  • Contact
  • Support Us
© Sama – Resource Group for Women and Health, 2021
Powered by Parabola & WordPress.
Facebook Twitter YouTube RSS